Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 3203-3209

  Lee, Chang Moon ^a   Jeong, Hwan Jeong ^a   Yun, Kuk No ^a   Kim, Dong Wook ^a   Sohn, Myung Hee ^a   Lee, Jong Kwon ^b   Jeong, Jayoung ^b   Lim, Seok Tae ^a  

^a Chonbuk National University Medical School   (South Korea)

^b National Institute of Food and Drug Safety Evaluation   (South Korea)

Author keywords

Biodistribution; Optical imaging; Oral administration; Zinc oxide nanoparticles

Indexed keywords

CYSTEINE; NANOCONJUGATE; NANOPARTICLE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GASTROINTESTINAL MUCOSA; IN VIVO STUDY; KIDNEY PARENCHYMA; LIVER PARENCHYMA; LUNG PARENCHYMA; MOLECULAR IMAGING; MOLECULAR STABILITY; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; RAT; STOMACH PH;

ADMINISTRATION, ORAL; ANIMALS; CARBOCYANINES; FLUORESCENT DYES; GASTRIC JUICE; GASTROINTESTINAL TRACT; METAL NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE; TISSUE DISTRIBUTION; WHOLE BODY IMAGING; ZINC OXIDE;

MUS; RATTUS;

EID: 84870352902     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S32828     Document Type: Article

References (23)

1. Jokerst JV, Gambhir SS. Molecular imaging with theranostic nanoparticles. Acc Chem Res. 2011;44:1050-1060.
2. Ray P. Multimodality molecular imaging of disease progression in living subjects. J Biosci. 2011;36:499-504.
3. Luo S, Zhang E, Su Y, Cheng T, Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials. 2011;32:7127-7138.
4. Nerl HC, Cheng C, Goode AE, etal. Imaging methods for determining uptake and toxicity of carbon nanotubes in vitro and in vivo. Nanomedicine (Lond). 2011;6:6849-6865.
5. Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv. 2010;7:1063-1077.
6. Hackenberg S, Zimmermann FZ, Scherzed A, etal. Repetitive exposure to zinc oxide nanoparticles induces DNA damage in human nasal mucosa mini organ cultures. Environ Mol Mutagen. 2011;52:582-589.
7. Teow Y, Asharani PV, Hande MP, Valiyaveettil S. Health impact and safety of engineered nanomaterials. Chem Commun. 2011;47:7025-7038.
8. Sharma V, Singh P, Pandey AK, Dhawan A. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat Res. 2012;745:84-91.
9. Sharma V, Anderson D, Dhawan A. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis. March 7, 2012. [Epub ahead of print].
10. Chen JK, Shih MH, Peir JJ, etal. The use of radioactive zinc oxide nanoparticles in determination of their tissue concentrations following intravenous administration in mice. Analyst. 2010;135:1742-1746.
11. Li CH, Shen CC, Cheng YW, etal. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology. September 27, 2011. [Epub ahead of print].
12. Maneewattanapinyo P, Banlunara W, Thammacharoen C, Ekgasit S, Kaewamatawong T. An evaluation of acute toxicity of colloidal silver nanoparticles. J Vet Med Sci. 2011;73:1417-1423.
13. Loeschner K, Hadrup N, Qvortrup K, etal. Distribution of silver in rats following 28days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol. 2011;8:18.
14. Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM, Tice TR. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Control Release. 1990;11:205-214.
15. Crayton SH, Elias DR, Al Zaki A, Cheng Z, Tsourkas A. ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance. Biomaterials. 2012;33:1509-1519.
16. Pasupuleti S, Alapati S, Ganapathy S, Anumolu G, Pully NR, Prakhya BM. Toxicity of zinc oxide nanoparticles through oral route. Toxicol Ind Health. October 27, 2011. [Epub ahead of print].
17. Sidhu P, Garg ML, Dhawan DK. Effect of zinc on biological half-lives of 65Zn in whole body and liver and on distribution of 65Zn in different organs of rats following nickel toxicity. Biol Trace Elem Res. 2004;102:173-188.
18. Hallmans G, Lidén S. Penetration of 65Zn through the skin of rats. Acta Derm Venereol. 1979;59:105-112.
19. Zvyagin AV, Zhao X, Gierden A, Sanchez W, Ross JA, Roberts MS. Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. J Biomed Opt. 2008;13:064031.
20. Areses P, Agüeros MT, Quincoces G, etal. Molecular imaging techniques to study the biodistribution of orally administered 99 mTc-labelled naive and ligand-tagged nanoparticles. Mol Imaging Biol. 2011;13:1215-1223.
21. Newton JM. Gastric emptying of multi-particulate dosage forms. Int J Pharm. 2010;395:2-8.
22. Xia D, Cui F, Piao H, etal. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats. Pharm Res. 2010;27:1965-1976.
23. Awaad A, Nakamura M, Ishimura K. Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer's patches using fluorescent organosilica particles. Nanomedicine. September 1, 2011. [Epub ahead of print].